Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation

2.

Magistro

G

,

Weinhold

P

,

Stief

CG

,

Gratzke

C

.

The new kids on the block: Prostatic urethral lift (Urolift) and convective water vapor energy ablation (Rezūm)

.

Curr Opin Urol

.

2018 May

;

28

(

3

):

294

–

300

.

3.

Gratzke

C

,

Bachmann

A

,

Descazeaud

A

,

Drake

MJ

,

Madersbacher

S

,

Mamoulakis

C

,

EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction

.

Eur Urol

.

2015 Jun

;

67

(

6

):

1099

–

110

.

4.

Magistro

G

,

Chapple

CR

,

Elhilali

M

,

Gilling

P

,

McVary

KT

,

Roehrborn

CG

,

Emerging minimally invasive treatment options for male lower urinary tract symptoms

.

Eur Urol

.

2017 Dec

;

72

(

6

):

986

–

97

.

5.

Sountoulides

P

,

Karatzas

A

,

Gravas

S

.

Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction

.

Ther Adv Urol

.

2019

;

11

:

1756287219828971

.

https://doi.org/10.1038/ijir.2017.30

6.

Cimino

S

,

Voce

S

,

Palmieri

F

,

Favilla

V

,

Castelli

T

,

Privitera

S

,

Transurethral resection of the prostate (TURP) vs. GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up

.

Int J Impot Res

.

2017

;

29

(

6

):

240

–

3

.

.

https://doi.org/10.1111/bju.13714

7.

Gratzke

C

,

Barber

N

,

Speakman

MJ

,

Berges

R

,

Wetterauer

U

,

Greene

D

,

Prostatic urethral lift vs. transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study

.

BJU Int

.

2017

;

119

(

5

):

767

.

.

https://doi.org/10.1016/j.eururo.2015.04.024

8.

Sønksen

J

,

Barber

NJ

,

Speakman

MJ

,

Berges

R

,

Wetterauer

U

,

Greene

D

,

Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study

.

Eur Urol

.

2015

;

68

(

4

):

643

.

.

9.

Sterne

JA

,

Hernán

MA

,

Reeves

BC

,

Savović

J

,

Berkman

ND

,

Viswanathan

M

,

Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance

.

BMJ

.

2016 Oct 12

;

355

:

i4919

.

10.

Higgins

JP

,

Altman

DG

,

Gøtzsche

PC

,

Jüni

P

,

Moher

D

,

Oxman

AD

,

The cochrane collaboration’s tool for assessing risk of bias in randomised trials

.

BMJ

.

2011 Oct 18

;

343

:

d5928

.

https://doi.org/10.1111/bju.12982

11.

Porpiglia

F

,

Fiori

C

,

Bertolo

R

,

Garrou

D

,

Cattaneo

G

,

Amparore

D

.

Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up

.

BJU Int

.

2015

;

116

(

2

):

278

.

.

12.

Porpiglia

F

,

Fiori

C

,

Amparore

D

,

Kadner

G

,

Manit

A

,

Valerio

M

,

Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up

.

BJU Int

.

2019 Jun

;

123

(

6

):

1061

–

9

.

13.

Porpiglia

F

,

Fiori

C

,

Bertolo

R

,

Giordano

A

,

Checcucci

E

,

Garrou

D

,

3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction

.

BJU Int

.

2018 Jul

;

122

(

1

):

106

–

12

.

14.

Kadner

G

,

Valerio

M

,

Giannakis

I

,

Manit

A

,

Lumen

N

,

Ho

BSH

,

Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study

.

World J Urol

.

2020 Dec

;

38

(

12

):

3235

–

44

.

15.

Gilling

P

,

Reuther

R

,

Kahokehr

A

,

Fraundorfer

M

.

Aquablation: image-guided robot-assisted waterjet ablation of the prostate: Initial clinical experience

.

BJU Int

.

2016 Jun

;

117

(

6

):

923

–

9

.

16.

Gilling

P

,

Barber

N

,

Bidair

M

,

Anderson

P

,

Sutton

M

,

Aho

T

,

WATER: a double-blind, randomized, controlled trial of Aquablation® vs. transurethral resection of the prostate in benign prostatic hyperplasia

.

J Urol

.

2018 May

;

199

(

5

):

1252

–

61

.

https://doi.org/10.1016/j.juro.2017.01.056

17.

Gilling

P

,

Anderson

P

,

Tan

A

.

Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results

.

J Urol

.

2017

;

197

(

6

):

1565

.

.

18.

Misrai

V

,

Rijo

E

,

Zorn

KC

,

Barry-Delongchamps

N

,

Descazeaud

A

.

Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first French Aquablation clinical registry

.

Eur Urol

.

2019 Nov

;

76

(

5

):

667

–

75

.

19.

Gilling

PJ

,

Barber

N

,

Bidair

M

,

Anderson

P

,

Sutton

M

,

Aho

T

,

Randomized controlled trial of aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia: one-year outcomes

.

Urology

.

2019 Mar

;

125

:

169

–

73

.

20.

Gilling

P

,

Barber

N

,

Bidair

M

,

Anderson

P

,

Sutton

M

,

Aho

T

,

Two-year outcomes after aquablation compared to TURP: efficacy and ejaculatory improvements sustained

.

Adv Ther

.

2019 Jun

;

36

(

6

):

1326

–

36

.

21.

Kasivisvanathan

V

,

Hussain

M

.

Aquablation versus transurethral resection of the prostate: 1 year United States: cohort outcomes

.

Can J Urol

.

2018 Jun

;

25

(

3

):

9317

–

22

.

https://doi.org/10.3410/f.734638920.793563998

22.

Plante

M

,

Gilling

P

,

Barber

N

,

Bidair

M

,

Anderson

P

,

Sutton

M

,

Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial

.

BJU Int

.

2019 Apr

;

123

(

4

):

651

–

60

.

.

23.

Gilling

P

,

Barber

N

,

Bidair

M

,

Anderson

P

,

Sutton

M

,

Aho

T

,

Three-year outcomes after aquablation therapy compared to TURP: results from a blinded randomized trial

.

Can J Urol

.

2020 Feb

;

27

(

1

):

10072

–

9

.

24.

Desai

MM

,

Singh

A

,

Abhishek

S

,

Laddha

A

,

Pandya

H

,

Ashrafi

AN

,

Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients

.

BJU Int

.

2018 Jun

;

121

(

6

):

945

–

51

.

25.

Desai

M

,

Bidair

M

,

Bhojani

N

,

Trainer

A

,

Arther

A

,

Kramolowsky

E

,

“WATER II (80–150 mL) procedural outcomes

.

BJU Int

.

2019 Jan

;

123

(

1

):

106

–

12

.

26.

Yafi

FA

,

Tallman

CT

,

Seard

ML

,

Jordan

ML

.

Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80–150 cc)

.

Int J Impot Res

.

2018 Oct

;

30

(

5

):

209

–

14

.

27.

Zorn

KC

,

Goldenberg

SL

,

Paterson

R

,

So

A

,

Elterman

D

,

Bhojani

N

.

Aquablation among novice users in Canada: a WATER II subpopulation analysis

.

Can Urol Assoc J

.

2019 May

;

13

(

5

):

E113

–

8

.

28.

Desai

M

,

Bidair

M

,

Zorn

KC

,

Trainer

A

,

Arther

A

,

Kramolowsky

E

,

Aquablation for benign prostatic hyperplasia in large prostates (80–150 mL): 6-month results from the WATER II trial

.

BJU Int

.

2019 Aug

;

124

(

2

):

321

–

8

.

29.

Bhojani

N

,

Bidair

M

,

Zorn

KC

,

Trainer

A

,

Arther

A

,

Kramolowsky

E

,

Aquablation for benign prostatic hyperplasia in large prostates (80–150 cc): 1-year results

.

Urology

.

2019 Jul

;

129

:

1

–

7

.

30.

Bhojani

N

,

Nguyen

DD

,

Kaufman

RP

Jr,

Elterman

D

,

Zorn

KC

.

Comparison of <100 cc prostates and >100 cc prostates undergoing aquablation for benign prostatic hyperplasia

.

World J Urol

.

2019 Jul

;

37

(

7

):

1361

–

8

.

31.

Nguyen

DD

,

Barber

N

,

Bidair

M

,

Gilling

P

,

Anderson

P

,

Zorn

KC

,

Badlani

G

,

Waterjet ablation therapy for endoscopic resection of prostate tissue trial (WATER) vs. WATER II: comparing aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates

.

BJU Int

.

2020 Jan

;

125

(

1

):

112

–

22

.

32.

Chughtai

B

,

Thomas

D

.

Pooled aquablation results for American men with lower urinary tract symptoms due to benign prostatic hyperplasia in large prostates (60–150 cc)

.

Adv Ther

.

2018 Jun

;

35

(

6

):

832

–

8

.

33.

Bach

T

,

Giannakis

I

,

Bachmann

A

,

Fiori

C

,

Gomez-Sancha

F

,

Herrmann

TRW

,

Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort

.

World J Urol

.

2019 Jul

;

37

(

7

):

1369

–

75

.

34.

Eure

G

,

Gange

S

,

Walter

P

,

Khan

A

,

Chabert

C

,

Mueller

T

,

Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a Retrospective Multicenter Study

.

J Endourol

.

2019 Jul

;

33

(

7

):

576

–

84

.

35.

Rukstalis

D

,

Grier

D

,

Stroup

SP

,

Tutrone

R

,

deSouza

E

,

Freedman

S

,

Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study

.

Prostate Cancer Prostatic Dis

.

2019 Sep

;

22

(

3

):

411

–

9

.

36.

Schoenthaler

M

,

Sievert

KD

,

Schoeb

DS

,

Miernik

A

,

Kunit

T

,

Hein

S

,

Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of symptomatic lower urinary tract obstruction

.

World J Uro

.

2018 Jul

;

36

(

7

):

1111

–

6

.

37.

Sievert

KD

,

Schoenthaler

M

,

Berges

R

,

Toomey

P

,

Drager

D

,

Herlemann

A

,

Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years

.

World J Urol

.

2019 Jul

;

37

(

7

):

1353

–

60

.

38.

Bozkurt

A

,

Karabakan

M

,

Keskin

E

,

Hirik

E

,

Balci

MB

,

Nuhoglu

B

.

“Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

Urol Int

.

2016

;

96

(

2

):

202

–

6

.

https://doi.org/10.1111/bju.13666

39.

Rukstalis

D

,

Rashid

P

,

Bogache

WK

,

Tutrone

RF

,

Barkin

J

,

Chin

PT

,

24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham

.

BJU Int

.

2016

;

118

(

Suppl 3

):

14

.

.

40.

Shore

N

,

Freedman

S

,

Gange

S

,

Moseley

W

,

Heron

S

,

Tutrone

R

,

Prospective multi-center study elucidating patient experience after prostatic urethral lift

.

Can J Urol

.

2014

;

21

(

1

):

7094

.

41.

Mcvary

KT

,

Gange

SN

,

Shore

ND

,

Bolton

DM

,

Cowan

BE

,

Brown

BT

,

Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift

.

J Sex Med

.

2014 Jan

;

11

(

1

):

279

–

87

.

42.

Cantwell

AL

,

Bogache

WK

,

Richardson

SF

,

Tutrone

RF

,

Barkin

J

,

Fagelson

JE

,

Multicentre prospective crossover study of the “prostatic urethral lift” for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

BJU Int

.

2014

;

113

(

4

):

615

.

43.

Roehrborn

CG

,

Barkin

J

,

Gange

SN

,

Shore

ND

,

Giddens

JL

,

Bolton

DM

,

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study

.

Can J Urol

.

2017

;

24

(

3

):

8802

.

44.

Roehrborn

CG

,

Rukstalis

DB

,

Barkin

J

,

Gange

SN

,

Shore

ND

,

Giddens

JL

,

Three year results of the prostatic urethral L.I.F.T. study

.

Can J Urol

.

2015

;

22

(

3

):

7772

.

45.

Roehrborn

CG

,

Gange

SN

,

Shore

ND

,

Giddens

JL

,

Bolton

DM

,

Cowan

BE

,

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study

.

J Urol

.

2013 Dec

;

190

(

6

):

2161

–

7

.

https://doi.org/10.1016/j.urology.2011.10.021

46.

Chin

PT

,

Bolton

DM

,

Jack

G

,

Rashid

P

,

Thavaseelan

J

,

Yu

RJ

,

Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

Urology

.

2012

;

79

(

1

):

5

.

.

https://doi.org/10.1111/j.1464-410X.2011.10342.x

47.

Woo

HH

,

Chin

PT

,

McNicholas

TA

,

Gill

HS

,

Plante

MK

,

Bruskewitz

RC

,

Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

.

BJU Int

.

2011

;

108

(

1

):

82

.

.

https://doi.org/10.1016/j.eururo.2013.01.008

48.

McNicholas

TA

,

Woo

HH

,

Chin

PT

,

Bolton

D

,

Fernández Arjona

M

,

Sievert

KD

,

Minimally invasive prostatic urethral lift: Surgical technique and multinational experience

.

Eur Urol

.

2013

;

64

(

2

):

292

.

.

49.

Woo

HH

,

Bolton

DM

,

Laborde

E

,

Jack

G

,

Chin

PT

,

Rashid

P

,

Thavaseelan

J

,

Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

J Sex Med

.

2012 Feb

;

9

(

2

):

568

–

75

.

50.

Barkin

J

,

Giddens

J

,

Incze

P

,

Casey

R

,

Richardson

S

,

Gange

S

.

UroLift system for relief of prostate obstruction under local anesthesia

.

Can J Urol

.

2012

;

19

(

2

):

6217

.

https://doi.org/10.1111/bju.13714

51.

Gratzke

C

,

Barber

N

,

Speakman

MJ

,

Berges

R

,

Wetterauer

U

,

Greene

D

,

“Prostatic urethral lift vs. transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.”

BJU Int

.

2017 May

;

119

(

5

):

767

–

75

.

.

https://doi.org/10.1016/j.urology.2015.05.046

52.

Dixon

C

,

Cedano

ER

,

Pacik

D

,

Vit

V

,

Varga

G

,

Wagrell

L

,

Efficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

Urology

.

2015

;

86

(

5

):

1042

.

.

https://doi.org/10.2147/RRU.S119596

53.

Dixon

CM

,

Cedano

ER

,

Pacik

D

,

Vit

V

,

Varga

G

,

Wagrell

L

,

Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia

.

Res Rep Urol

.

2016

;

8

:

207

.

.

54.

McVary

KT

,

Gange

SN

,

Gittelman

MC

,

Goldberg

KA

,

Patel

K

,

Shore

ND

,

Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

.

J Urol

.

2016 May

;

195

(

5

):

1529

–

38

.

https://doi.org/10.1016/j.juro.2016.12.045

55.

Roehrborn

CG

,

Gange

SN

,

Gittelman

MC

,

Goldberg

KA

,

Patel

K

,

Shore

ND

,

Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

.

J Urol

.

2017

;

197

(

6

):

1507

.

.

56.

McVary

KT

,

Roehrborn

CG

.

Three-year outcomes of the prospective, randomized controlled Rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

.

Urology

.

2018 Jan

;

111

:

1

–

9

.

57.

McVary

KT

,

Rogers

T

,

Roehrborn

CG

.

Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized Controlled Study

.

Urology

.

2019 Apr

;

126

:

171

–

9

.

58.

Mollengarden

D

,

Goldberg

K

,

Wong

D

,

Roehrborn

C

.

Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience

.

Prostate Cancer Prostatic Dis

.

2018 Sep

;

21

(3):

379

–

85

.

https://doi.org/10.2147/RRU.S143679

59.

Darson

MF

,

Alexander

EE

,

Schiffman

ZJ

,

Lewitton

M

,

Light

RA

,

Sutton

MA

,

Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

.

Res Rep Urol

.

2017

;

9

:

159

.

.

60.

Gupta

N

,

Holland

B

,

Dynda

D

,

Köhler

T

,

McVary

K

.

PD27-02 comparison of convective radiofrequency water vapor energy ablation of proSTATE (REZUM®) to MTOPS trial cohort

.

J Urol

.

2017

;

197

(

4S

):

e511

.

61.

McVary

KT

,

Rogers

T

,

Mahon

J

,

Gupta

NK

.

Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia?

J Sex Med

.

2018 Dec

;

15

(

12

):

1728

–

38

.

62.

Gupta

N

,

Rogers

T

,

Holland

B

,

Helo

S

,

Dynda

D

,

McVary

KT

.

Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial

.

J Urol

.

2018 Aug

;

200

(

2

):

405

–

13

.

63.

McVary

KT

,

Holland

B

,

Beahrs

JR

.

Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia

.

Prostate Cancer Prostatic Dis

.

2019 Jun

;

23

(

2

):

303

–

8

.